Two separate tyrosine protein kinases in human platelets  by Nakamura, Shun-ichi et al.
Volume 184, number 1 FEBS 2514 May 1985 
Two separate tyrosine protein kinases in human platelets 
Shun-ichi Nakamura, Fumito Takeuchi, Tamami Tomizawa, Noriko Takasaki, Hiroki Kondo+ 
and Hirohei Yamamura* 
Department of Biochemistry, Fukui Medical School, Matsuoka, Fukui 910-11 and +Department of Industrial Chemistry, 
Faculty of Engineering, Nagasaki University, Bunkyo, Nagasaki 825, Japan 
Received 7 February 1985 
Tyrosine protein kinase activities were detected in the cytosolic fraction (PC-TPK) and the particulate frac- 
tion (PM-TPK) in human platelets using the synthetic peptide, EllG, (Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg- 
Arg-Arg-Gly) as a substrate. PC-TPK and PM-TPK were different in substrate specificities, divalent cation 
requirements and apparent IU, values. These results strongly suggest hat in platelets there exist at least two 
separate tyrosine protein kinases; one is present in cytosol and the other might be associated with 
membranes. 
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1. INTRODUCTION 
A newly described class of protein kinases that 
selectively phosphorylate tyrosine residues has 
been linked to virus transformation [l-7] and 
growth stimulation with certain growth factors 
[8- 131 and normal cellular proteins homologous to 
certain virus transforming protein [ 14- 161. These 
unique protein kinases are believed to be involved 
in the regulation of proliferation of normal and 
malignant cells. Recently it has been found that 
high tyrosine protein kinase activities are 
associated with normal hematopoietic cells in- 
cluding platelets [ 17-201. Since platelets lack 
nucleus, tyrosine residue phosphorylation does not 
seem to be related to the proliferation of cells. So 
it is of interest to characterize tyrosine protein 
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kinase in platelets and to reveal its role in cellular 
function. 
Here, we found high tyrosine protein kinase ac- 
tivities not only in the particulate fraction (PM- 
TPK) but in the cytosolic fraction (PC-TPK) using 
platelets, and these enzyme properties are briefly 
studied. 
2. MATERIALS AND METHODS 
A synthetic peptide, EllGl (Glu-Asp-Ala-Glu- 
Tyr-Ala-Ala-Arg-Arg-Arg-Gly) was prepared as in 
[21]. (Val’)Angiotensin II was purchased from 
Sigma. [Y-~~P]ATP was prepared as in 1221. All 
other chemicals of the highest grade were obtained 
from commercial sources. 
Human platelets were prepared from 40-50 ml 
of fresh blood as in [23]. Washed platelets were 
suspended in cold buffer A (50 mM Tris-HCl at 
pH 7.5,2 mM MgClz, 1 mM EDTA, 1 mM TLCK 
and 1 mM TPCK) and were sonicated on ice with 
constant stirring. The sonicate was centrifuged at 
1000 x g for 10 min to remove unbroken cells. The 
resultant supernatnt was then centrifuged at 4°C at 
48000 x g for 30 min. After this treatment, the 
supernatant fraction was used as a source of PC- 
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TPK. Some of the particulate fractions were 
resuspended in the buffer A containing 5% NP 40 
and stood on ice for 1 h and then centrifuged at 
100000 x g for 60 min. The resultant supernatant 
was applied to a hydroxyapatite column (1 ml) 
equilibrated with buffer A. The column was 
washed with 10 ml of buffer A and then washed 
with 250 mM potassium phosphate buffer at pH 
7.0 in buffer A. The detergent-soluble nzyme at 
this step or particulate fraction were used as 
sources of PM-TPK as indicated elsewhere. Tyro- 
sine protein kinase activity was measured using the 
synthetic peptide as a substrate as in [24]. Protein 
concentration was determined as in [25]. All ex- 
periments were carried out with at least 3 prepara- 
tions and assays were carried out in duplicate. 
3. RESULTS 
The cytosolic and particulate fractions of human 
platelets were analyzed for tyrosine protein kinase 
activity using the peptide, ErrGi, having an amino 
acid sequence similar to that of the tyrosine 
phosphorylation site of pp60”” as a substrate (table 
1). In our assay system employed here, the par- 
ticulate fraction of platelets contained very high 
tyrosine protein kinase activity (PM-TPK). Under 
the same conditions the cytosolic fraction also had 
a substantial amount of tyrosine protein kinase ac- 
tivity (PC-TPK). 
To further distinguish PC-TPK from PM-TPK, 
some of the enzyme properties were characterized 
Table 1 
Intracellular distribution of tyrosine protein kinase 
activity in human platelets 
Preparation Protein Total Specific 
(mg) activity activity 
(pmol/min) @mol/min 
per mg) 
Cytosolic 11.9 262 22 
Particulate 6.3 790 126 
The cytosolic and the particulate fractions were assayed 
for tyrosine protein kinase activity by estimating the 
phosphorylation of ErrGr (1 mg/ml) in the presence of 
6OpM [y-32P]ATP, 50 mM MgClz, 0.05% NP 40 and 
10 pM vanadate as in [24]. The amount of protein used 
was 20 pg/tube for cytosolic enzyme and 10 pg/tube for 
particulate enzyme 
and compared. Fig.1 shows different rates of pep- 
tide phosphorylation by PC-TPK and PM-TPK. In 
PC-TPK (Val’)angiotensin II was a better 
substrate than Err@ (fig.lA). On the other hand, 
PM-TPK phosphorylated ErrGr more efficiently 
than (Va15)angiotensin II under the same condi- 
tions (fig. 1B). By using solubilized instead of non- 
solubilized PM-TPK we obtained a similar result 
(not shown). 
For further characterization of PC-TPK and 
PM-TPK, divalent cation requirements were tested 
(fig.2). Both Mg2+ and Mn2+ could serve as 
r 
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Fig. 1. Peptide substrate specificity of PC-TPK and PM- 
TPK in platelets. Tyrosine protein kinase activity with 
each peptide was determined at 1 mg/ml concentration 
for the various time periods indicated. Other conditions 
as in table 1. (A) With PC-TPK, (B) with PM-TPK. (0) 
E&r phosphorylation; (0) (Val’)angiotensin II 
phosphorylation. 
I IO 100 0.1 I IO 
Mg” (mM 1 Mn” ( mM) 
Fig.2. Effects of divalent cations on the phosphorylation 
of ErrGr by PC-TPK and PM-TPK in platelets. Tyrosine 
protein kinase activities of both enzymes were measured 
as a function of various concentrations of divalent 
cations. Assay conditions as in table 1. (A) With Mg2+, 
(B) with Mn2+. (0) With PC-TPK, (0) with PM-TPK. 
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Fig.3. Molecular masses of PC-TPK and PM-TPK from 
sucrose density gradient sedimentation. 100 ~1 of either 
PC-TPK or PM-TPK was applied to a 5-20% sucrose 
density gradient in buffer A containing 0.4 M KCI. 
After centrifugation at 37700 rpm for 35 h in a Hitachi 
SW 50 rotor, 30 fractions were collected from the 
bottom of the tube (0.18 ml/fraction) and an aliquot 
(30~1) was assayed for ErrGr phosphorylation as in 
table 1. (0) With PC-TPK, (0) with PM-TPK. 
Standards of human y-globulin (a), bovine serum 
albumin (b), ovalbumin (c) and cytochrome c (d) were 
run on parallel gradients and located by UV absorption. 
divalent cations in both kinases, but these enzymes 
showed apparently different concentrations of 
each metal ion requirement for maximal activity. 
PM-TPK required 20-50 mM Mg2+ and 1-2 mM 
Mn*+ for maximal activity, whereas PC-TPK re- 
quired much higher concentrations of both metal 
ions. By using solubilized PM-TPK the same 
results were obtained as with non-solubilized PM- 
TPK (not shown). 
To show the difference between PC-TPK and 
PM-TPK more clearly, the apparent M, values of 
both enzymes were estimated by sucrose density 
gradient sedimentation (fig.3). The apparent Mr 
values of PC-TPK and solubilized PM-TPK in this 
system were about 70000 and 52000, respectively. 
These results strongly suggest hat there exist at 
least two tyrosine protein kinases in platelets; one 
is present in the cytosol and the other is 
presumably associated with membranes. 
4. DISCUSSION 
Two tyrosine protein kinases were found to be 
present in the cytosolic (PC-TPK) and particulate 
fractions (PM-TPK). PM-TPK may probably be 
related to or identical with a 60-kDa protein 
previously reported in [17]. PC-TPK may be a 
novel type of tyrosine protein kinase that has not 
yet been reported or be related to the cytosolic 
tyrosine protein kinase in bone marrow cells [26]. 
The different enzyme properties of PC-TPK and 
PM-TPK, such as substrate specificity, divalent 
cation requirement and apparent molecular mass 
strongly suggest hat the tyrosine protein kinase in 
cytosol, if not completely exclusiv% is separate 
from that associated with membranes. Recently, 
several lines of evidence have suggested that high 
tyrosine protein kinase activities are associated 
with normal non-proliferating cells [17,27,28]. To 
discover the role of tyrosine protein kinases in such 
cells, the study of tyrosine residue phosphorylation 
in platelets hould supply us with a lot of informa- 
tion about cellular regulation. Particularly, it has 
recently been postulated that protein phosphoryla- 
tion by protein kinase C plays an important role in 
platelet activation by thrombin [29]. It is very at- 
tractive to assume that either of the tyrosine pro- 
tein kinases we described in this paper might be in- 
volved in the cellular function of platelets along 
with protein kinase C. 
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